Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
swelling, pain, warmth, redness, oozing, or other signs of infection;
blistering or crusting; or
severe irritation, itching, or burning.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Delvodip side effects (more detail)
Side effects of Delvodip in details
A side effect of any drug can be defined as the unwanted or undesired effect produced by the drug. The side effect can be major or in few medications minor that can be ignored. Side effects not only vary from drug to drug, but it also depends on the dose of the drug, the individual sensitivity of the person, brand or company which manufactures it. If side effects overweigh the actual effect of the medicine, it may be difficult to convince the patient to take the drug. Few patients get specific side effects to specific drugs; in that case, a doctor replaces the drug with another. If you feel any side effect and it troubles you, do not forget to share with your healthcare practitioner.
Delvodip and iodides, whether applied topically or given systemically, can give rise to hypersensitivity reactions which may include urticaria, angioedema, cutaneous haemorrhage or purpuras, fever, arthralgia, lymphadenopathy, and eosinophilia.
Inhalation of Delvodip vapour is very irritating to mucous membranes.
Delvodip and iodides have variable effects on the thyroid and can produce goitre and hypothyroidism as well as hyperthyroidism (the Iod-Basedow or Jod-Basedow phenomenon). Goitre and hypothyroidism have also occurred in infants born to mothers who had taken iodides during pregnancy.
Prolonged use may lead to a range of adverse effects, often called ’iodism’, some of which may again be due to hypersensitivity. Adverse effects include metallic taste, increased salivation, burning or painful mouth; there may be acute rhinitis, coryza-like symptoms, and swelling and inflammation of the throat. Eyes may be irritated and swollen and there may be increased lachrymation. Pulmonary oedema, dyspnoea, and bronchitis may develop. Skin reactions include acneform or, more rarely, severe eruptions (iododerma). Other reported effects include depression, insomnia, impotence, headache, and gastrointestinal disturbances, notably nausea, vomiting, and diarrhoea.
Contraindication can be described as a special circumstance or a disease or a condition wherein you are not supposed to use the drug or undergo particular treatment as it can harm the patient; at times, it can be dangerous and life threatening as well. When a procedure should not be combined with other procedure or when a medicine cannot be taken with another medicine, it is called Relative contraindication. Contraindications should be taken seriously as they are based on the relative clinical experience of health care providers or from proven research findings.
Allergy to Delvodip,
- Class III patients with Okuda
- Extrahepatic metastases,
- Respiratory or renal insufficiencies severe
- Cons-indications for hepatic arteriography,
- Leukopenia below 1500/mm3 or thrombocytopenia less 50000/mm3,
- Pregnant woman: Delvodip should not be administered to pregnant women. In women of childbearing age, suspicion of pregnancy must be excluded before the administration of Delvodip. Contraception must be instituted and prosecuted in the administration at least a year.
- Breastfeeding: Breastfeeding should be stopped.
DTP/NCI. "iodine: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
European Chemicals Agency - ECHA. "Iodine: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
HSDB. "IODINE, ELEMENTAL: This record contains information for iodine in its zero valence state only. Although iodine is caustic to tissues in immediate contact, it is readily converted to iodide within the body; for additional compound-specific information, refer to the appropriate iodide records as listed in the RELATED HSDB RECORDS field. For information on the radiological aspects of iodine and its compounds, refer to the IODINE, RADIOACTIVE record For general toxicological, safety and handling, and environmental information on ionizing radiation emitted from chemical sources including uranium, refer to the IONIZING RADIATION RECORD.". https://toxnet.nlm.nih.gov/cgi-bin/s... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Delvodip are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Delvodip. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported side effects
No survey data has been collected yet
There are no reviews yet. Be the first to write one!